BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

21 related articles for article (PubMed ID: 18220025)

  • 1. First-line diuretics versus other classes of antihypertensive drugs for hypertension.
    Reinhart M; Puil L; Salzwedel DM; Wright JM
    Cochrane Database Syst Rev; 2023 Jul; 7(7):CD008161. PubMed ID: 37439548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
    Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
    Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
    Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical and vascular effects of ACE inhibitor enalapril in combination with thiaside-like diuretic indapamide in hypertensive outpatients. Results of the multicenter trial POEMA].
    Belenkov IuN; Ageev FT; Orolova IaA; Abrosimova OIu; Volkova EG; Gapon LI; Katel'nitskaia LI; Kondari AO; Patrusheva IF; Fomin IV; Khokhlov RA
    Ter Arkh; 2007; 79(8):33-8. PubMed ID: 17926468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disturbed circadian blood pressure rhythm and C-reactive protein in essential hypertension.
    Tsioufis C; Syrseloudis D; Dimitriadis K; Thomopoulos C; Tsiachris D; Pavlidis P; Selima M; Kallikazaros I; Stefanadis C
    J Hum Hypertens; 2008 Jul; 22(7):501-8. PubMed ID: 18385743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diverse associations of microalbuminuria with C-reactive protein, interleukin-18 and soluble CD 40 ligand in male essential hypertensive subjects.
    Tsioufis C; Dimitriadis K; Taxiarchou E; Vasiliadou C; Chartzoulakis G; Tousoulis D; Manolis A; Stefanadis C; Kallikazaros I
    Am J Hypertens; 2006 May; 19(5):462-6. PubMed ID: 16647614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of microalbuminuria with inflammation markers in hypertensive men.
    Bautista LE
    Am J Hypertens; 2006 May; 19(5):467. PubMed ID: 16647615
    [No Abstract]   [Full Text] [Related]  

  • 8. [Inflammation and arterial hypertension in rheumatic diseases].
    Shilkina NP; Driashenkova IV
    Klin Med (Mosk); 2012; 90(1):13-6. PubMed ID: 22567932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The activity of nonspecific inflammation in hypertensive patients].
    Oshchepkova EV; Dmitriev VA; Titiov VN; Rogoza AN; Masenko VP
    Ter Arkh; 2007; 79(12):18-25. PubMed ID: 18220025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertension: which aspects of hypertension should we impact on and how?
    Zanchetti A; Waeber B
    J Hypertens Suppl; 2006 Aug; 24(5):S2-5. PubMed ID: 16936532
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.